BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31413733)

  • 1. PALB2 (partner and localizer of BRCA2).
    Hanenberg H; Andreassen PR
    Atlas Genet Cytogenet Oncol Haematol; 2018 Apr; 22(12):484-490. PubMed ID: 31413733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair.
    Park JY; Singh TR; Nassar N; Zhang F; Freund M; Hanenberg H; Meetei AR; Andreassen PR
    Oncogene; 2014 Oct; 33(40):4803-12. PubMed ID: 24141787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of PALB2 in the DNA Damage Response and Cancer Predisposition.
    Nepomuceno TC; De Gregoriis G; de Oliveira FMB; Suarez-Kurtz G; Monteiro AN; Carvalho MA
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28858227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ablation of the Brca1-Palb2 Interaction Phenocopies Fanconi Anemia in Mice.
    Park D; Bergin SM; Jones D; Ru P; Koivisto CS; Jeon YJ; Sizemore GM; Kladney RD; Hadjis A; Shakya R; Ludwig T
    Cancer Res; 2020 Oct; 80(19):4172-4184. PubMed ID: 32732220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PALB2 functionally connects the breast cancer susceptibility proteins BRCA1 and BRCA2.
    Zhang F; Fan Q; Ren K; Andreassen PR
    Mol Cancer Res; 2009 Jul; 7(7):1110-8. PubMed ID: 19584259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PALB2 is an integral component of the BRCA complex required for homologous recombination repair.
    Sy SM; Huen MS; Chen J
    Proc Natl Acad Sci U S A; 2009 Apr; 106(17):7155-60. PubMed ID: 19369211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PALB2/FANCN: recombining cancer and Fanconi anemia.
    Tischkowitz M; Xia B
    Cancer Res; 2010 Oct; 70(19):7353-9. PubMed ID: 20858716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PALB2: the hub of a network of tumor suppressors involved in DNA damage responses.
    Park JY; Zhang F; Andreassen PR
    Biochim Biophys Acta; 2014 Aug; 1846(1):263-75. PubMed ID: 24998779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer.
    Bowman-Colin C; Xia B; Bunting S; Klijn C; Drost R; Bouwman P; Fineman L; Chen X; Culhane AC; Cai H; Rodig SJ; Bronson RT; Jonkers J; Nussenzweig A; Kanellopoulou C; Livingston DM
    Proc Natl Acad Sci U S A; 2013 May; 110(21):8632-7. PubMed ID: 23657012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAD52 inactivation is synthetically lethal with deficiencies in BRCA1 and PALB2 in addition to BRCA2 through RAD51-mediated homologous recombination.
    Lok BH; Carley AC; Tchang B; Powell SN
    Oncogene; 2013 Jul; 32(30):3552-8. PubMed ID: 22964643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (PALB2).
    McReynolds LJ; Biswas K; Giri N; Sharan SK; Alter BP
    Cancer Genet; 2021 Nov; 258-259():101-109. PubMed ID: 34687993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Male fertility defect associated with disrupted BRCA1-PALB2 interaction in mice.
    Simhadri S; Peterson S; Patel DS; Huo Y; Cai H; Bowman-Colin C; Miller S; Ludwig T; Ganesan S; Bhaumik M; Bunting SF; Jasin M; Xia B
    J Biol Chem; 2014 Aug; 289(35):24617-29. PubMed ID: 25016020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the roles of PALB2 at the crossroads of DNA repair and cancer.
    Pauty J; Rodrigue A; Couturier A; Buisson R; Masson JY
    Biochem J; 2014 Jun; 460(3):331-42. PubMed ID: 24870022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PALB2 connects BRCA1 and BRCA2 in the G2/M checkpoint response.
    Simhadri S; Vincelli G; Huo Y; Misenko S; Foo TK; Ahlskog J; Sørensen CS; Oakley GG; Ganesan S; Bunting SF; Xia B
    Oncogene; 2019 Mar; 38(10):1585-1596. PubMed ID: 30337689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XRCC2 (X-ray repair cross complementing 2).
    Andreassen PR; Hanenberg H
    Atlas Genet Cytogenet Oncol Haematol; 2019 Jan; 23(1):1-7. PubMed ID: 31275435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterozygous mutations in the PALB2 hereditary breast cancer predisposition gene impact on the three-dimensional nuclear organization of patient-derived cell lines.
    Wark L; Novak D; Sabbaghian N; Amrein L; Jangamreddy JR; Cheang M; Pouchet C; Aloyz R; Foulkes WD; Mai S; Tischkowitz M
    Genes Chromosomes Cancer; 2013 May; 52(5):480-94. PubMed ID: 23341105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiparallel Coiled-Coil Interactions Mediate the Homodimerization of the DNA Damage-Repair Protein PALB2.
    Song F; Li M; Liu G; Swapna GVT; Daigham NS; Xia B; Montelione GT; Bunting SF
    Biochemistry; 2018 Nov; 57(47):6581-6591. PubMed ID: 30289697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compensatory functions and interdependency of the DNA-binding domain of BRCA2 with the BRCA1-PALB2-BRCA2 complex.
    Al Abo M; Dejsuphong D; Hirota K; Yonetani Y; Yamazoe M; Kurumizaka H; Takeda S
    Cancer Res; 2014 Feb; 74(3):797-807. PubMed ID: 24285729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PALB2 analysis in BRCA2-like families.
    Adank MA; van Mil SE; Gille JJ; Waisfisz Q; Meijers-Heijboer H
    Breast Cancer Res Treat; 2011 Jun; 127(2):357-62. PubMed ID: 20582465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.